Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1619
This examiner grants 38% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 19289461 | SUNSCREEN COMPOSITION BASED ON BEMT AND TWO OR MORE PIGMENTARY UV-FILTERS | Non-Final OA | DSM IP ASSETS B.V. |
| 18263641 | SUNSCREEN COMPOSITION BASED ON BEMT AND TWO OR MORE PIGMENTARY UV-FILTERS | Non-Final OA | DSM IP ASSETS B.V. |
| 18252600 | MARINE COATING COMPOSITION | Non-Final OA | BAE SYSTEMS plc |
| 18298042 | MULTIPLE MEDIATORS TARGETED MULTIFUNCTIONAL NANOPARTICLES AND USES THEREOF | Non-Final OA | The Trustees of Columbia University in the City of New York |
| 18554917 | PHARMACEUTICAL COMPOSITIONS COMPRISING POH DERIVATIVES | Final Rejection | UNIVERSITY OF SOUTHERN CALIFORNIA |
| 18286771 | USE OF A CATIONIC POLYMER FOR REINFECTION PREVENTION | Non-Final OA | Conopco, Inc., d/b/a UNILEVER |
| 18286492 | CLEANSING COMPOSITION FOR FEMALE INTIMATE HYGIENE | Non-Final OA | Conopco, Inc., d/b/a UNILEVER |
| 18014382 | USE OF TREHALOSE FOR INHIBITING AILMENT INDUCING MICROORGANISMS | Non-Final OA | Conopco, Inc., d/b/a UNILEVER |
| 18492486 | Hair Perming Compositions With Amine Derivatives | Non-Final OA | ELC Management LLC |
| 18045575 | TERT IMMUNOGENIC COMPOSITIONS AND METHODS OF TREATMENT USING THE SAME | Final Rejection | INOVIO PHARMACEUTICALS, INC. |
| 18608901 | DEXTROMETHORPHAN AND GUAIFENESIN SYRUP FORMULATION | Non-Final OA | GENEXA INC. |
| 18201375 | SYRUP FORMULATION OR SUSPENSION | Non-Final OA | GENEXA INC. |
| 18245206 | COSMETIC COMPOSITION OF LOW OSMOLALITY | Final Rejection | BEIERSDORF AG |
| 18532935 | ANTIBACTERIAL DRESSING, METHOD FOR PREPARING THE SAME, AND APPLICATION THEREOF | Non-Final OA | Suzhou Microport Regenerative Medicine Technology Co. Ltd |
| 18197791 | ANTI-MICROBIAL COMPOSITION | Final Rejection | UWM Research Foundation, Inc. |
| 18386831 | NASAL ANTISEPTIC | Non-Final OA | PoviNez LLC |
| 18557089 | TOPICAL FORMULATIONS COMPRISING BENZOYL PEROXIDE AND AZELAIC ACID, AND USE THEREOF | Non-Final OA | NOON AESTHETICS M.R. LTD. |
| 18554422 | WHITENING COMPOSITION USEFUL FOR THE PREPARATION OF COSMETIC FORMULATIONS | Non-Final OA | SENSIENT COSMETIC TECHNOLOGIES |
| 17781862 | Medical Composition Comprising Adipose Tissue-Derived Extracellular Matrix And Method For Preparing Same | Final Rejection | L&C Bio Co., Ltd. |
| 18463663 | COMPOSITION FOR SKIN TREATMENT AND METHODS | Non-Final OA | DERMAZEN, LLC |
| 18258066 | ANHYDROUS SOLID COMPOSITION COMPRISING A MAGNESIUM SALT AND STARCH | Final Rejection | L’OREAL |
| 18258456 | ANTIMICROBIAL AGENT COMPOSITION AND MANUFACTURING METHOD AND PRODUCT THEREOF | Non-Final OA | Dong Chul IHN |
| 18033383 | Novel compositions for neutralizing toxic effects of hydrogen peroxide in living cells or tissues | Non-Final OA | Dzala LLC |
| 18249253 | GOLD CLUSTERS, COMPOSITIONS, AND METHODS FOR TREATMENT OF CEREBRAL ISCHEMIC STROKES | Non-Final OA | SHENZHEN PROFOUND VIEW PHARMACEUTICAL TECHNOLOGY CO., LTD. |
| 18030680 | MESOPOROUS NANOPARTICLES SYSTEM TO INCREASE THE BIOFILM ERADICATION ACTIVITY BY MEANS OF THE CARRYING AND THE ADMINISTRATION OF AT LEAST ONE ACTIVE INGREDIENT AND RELATED PRODUCTION METHOD | Non-Final OA | Brenta S.r.l. |
| 18248020 | COMBINATIONS TREATMENTS | Non-Final OA | Aequor, Inc. |
| 18016655 | METHODS OF TREATING CONDITIONS RESPONSIVE TO NTIRIC OXIDE THERAPY | Final Rejection | SaNOtize Research and Development Corp. |
| 18021504 | DISINFECTANT COMPOSITION | Final Rejection | Helperby Therapeutics Limited |
| 18103620 | DERIVATIZED COLLAGEN-HYALURONIC ACID BASED IMPLANTS FOR SUSTAINED DELIVERY OF OPHTHALMIC DRUGS | Final Rejection | SUSTAINED DRUG DELIVERY LLC |
| 18006744 | Anti-Microbial Compositions | Final Rejection | 5D HEALTH PROTECTION GROUP LTD |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy